DiaMonTech

DiaMonTech GmbH is a pioneering medical technology company based in Berlin, Germany, specializing in non-invasive blood glucose monitoring. The company has developed a breakthrough product, the DMT Base, which uses laser-based technology to measure blood glucose levels without the need for painful finger pricks. This innovative approach aims to significantly improve the quality of life for diabetes patients by providing a pain-free and convenient method for glucose monitoring.

DiaMonTech primarily serves diabetes patients in Germany, working closely with local pharmacies to distribute its products. The company operates in the healthcare and medical technology market, focusing on innovative solutions that address chronic health conditions. Its business model revolves around the development, certification, and distribution of medical devices, with revenue generated through product sales and partnerships with healthcare providers.

The company recently secured more than 7 million euros in a Series A financing round, led by Bioventure, a biotech and life science investor. This funding will support further development and commercialization of its technology. DiaMonTech's CE certification for the DMT Base confirms that its technology meets high safety and performance standards, positioning the company as a leader in non-invasive glucose monitoring.

Keywords: non-invasive, blood glucose, laser technology, diabetes management, medical device, CE certification, Series A financing, healthcare innovation, pain-free monitoring, Berlin.